NFE2L2 and cholangiocarcinoma: Hence, it is postulated that the synergistic photodynamic‐gaseous therapeutic effect on CCA can be achieved by combining chlorin e6 (Ce6) and NO donor (Arg) photosensitizers with an NRF2 inhibitor (ML385).